6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $308M | -$95572 | 63.7% | -33.7% | -$58M | $52M | $287M |
| 2024 | $224M | -$91413 | 61.1% | -43.0% | -$104M | $51M | $334M |
| 2023 | $136M | -$105897 | 52.2% | -80.2% | -$133M | $51M | $257M |
| 2022 | $75M | -$87154 | 49.4% | -107.6% | -$83M | $51M | $222M |
| 2021 | $34M | -$59853 | 46.0% | -157.1% | -$58M | $50M | $304M |
| 2020 | $8M | -$53M | -16.3% | -619.4% | -$49M | $49M | $100M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $83M | -$32M | 64.9% | -39.2% | -$41M | $52M | $246M |
| Dec '25 | $76M | -$30M | 60.6% | -40.6% | -$12M | $52M | $287M |
| Sep '25 | $83M | -$21M | 64.8% | -27.8% | -$10M | $52M | $294M |
| Jun '25 | $79M | -$20M | 65.4% | -28.0% | -$18M | $52M | $303M |
| Mar '25 | $69M | -$25M | 63.9% | -39.7% | -$19M | $51M | $316M |
| Dec '24 | $68M | -$19M | 64.0% | -28.9% | -$34M | $51M | $334M |
| Sep '24 | $58M | -$21M | 63.2% | -38.4% | -$19M | $51M | $197M |
| Jun '24 | $53M | -$26M | 59.0% | -50.3% | -$17M | $51M | $214M |
| Mar '24 | $45M | -$26M | 56.2% | -62.1% | -$34M | $51M | $226M |
| Dec '23 | $44M | -$28M | 48.8% | -67.8% | -$34M | $51M | $257M |
| Sep '23 | $35M | -$25M | 53.8% | -73.0% | -$25M | $51M | $287M |
| Jun '23 | $33M | -$25M | 55.7% | -77.4% | -$34M | $51M | $150M |
| Mar '23 | $24M | -$28M | 51.2% | -116.3% | -$41M | $51M | $181M |
| Dec '22 | $24M | -$28M | 44.9% | -105.3% | -$26M | $51M | $222M |
| Sep '22 | $20M | -$23M | 50.3% | -108.6% | -$21M | $51M | $249M |
| Jun '22 | $17M | -$19M | 50.8% | -107.1% | -$17M | $51M | $270M |
| Mar '22 | $14M | -$17M | 54.2% | -110.6% | -$18M | $50M | $284M |
| Dec '21 | $10M | -$18M | 44.5% | -166.0% | -$17M | $50M | $304M |
| Sep '21 | $9M | -$14M | 48.9% | -147.6% | -$13M | $50M | $320M |
| Jun '21 | $8M | -$15M | 42.3% | -155.6% | -$13M | — | $159M |
How the market has priced PRCT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Procept Biorobotics Corp's revenue has grown 109.0% per year. These are computed facts, not advice.
As of FY2025, Procept Biorobotics Corp reported $52M of total debt against $287M of cash; operating income covered interest expense -29.0×.
In FY2025, gross margin was 63.7%, operating margin -33.7%, and net margin -0.0%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.